查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1789442

冠状动脉支架市场按产品类型、材料、最终用户和地区划分

Coronary Stents Market, By Product Type, By Material, By End User, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 198 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年冠状动脉支架市场规模估计为 139.449 亿美元，预计到 2032 年将达到 237.909 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.93%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 139.449亿美元
效能数据 2020-2024 预测期 2025-2032
预测期：2025-2032年 7.93% 2032年预测 237.909亿美元

冠状动脉支架 (CS) 是一种可扩张的管状金属装置，当冠状动脉因潜在的动脉粥状硬化疾病而阻塞时，可将其引入冠状动脉，这是一种称为经皮冠状动脉介入治疗 (PCI) 或支架冠状动脉成形术的血管重组程序。

冠状动脉支架最早于 20 世纪 80 年代开发，其形状、结构和支架所用材料都在不断发展。

市场动态

预计在预测期内，监管产品核可的增加将推动市场成长。例如，2021年12月，致力于重新定义冠状动脉置入术术的私人公司Svelte Medical宣布，美国食品药物管理局(FDA)核准美国SLENDERSirolimus洗脱冠状动脉支架整合输送系统和DIRECTSirolimus洗脱冠状动脉支架快速交换输送系统，用于治疗冠状动脉狭窄患者。

冠状动脉疾病盛行率的不断上升预计将在预测期内推动市场成长。例如，美国疾病管制与预防中心 (CDC) 于 2022 年 10 月发表的报导指出，心臟病是美国最大的死亡原因，约有 2,010 万 20 岁及以上的美国成年人患有冠状动脉疾病 (CAD)。

本次调查的主要特点

  • 本报告对全球冠状动脉支架市场进行了详细分析，并提供了预测期 2025-2032 的市场规模（百万美元）和年复合成长率（CAGR%），以 2024 年为基准年。
  • 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、性能和策略等参数，对全球冠状动脉支架市场的主要企业进行了概述。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对全球冠状动脉支架市场的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过全球冠状动脉支架市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图（COM）

第三章：市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 抑制因素
    • 市场吸引力分析
    • 市场机会
  • 产品发布
  • 合併、收购和合作
  • 监理指南与合规性
  • PEST分析
  • 物质状况
  • 波特分析
  • 价格分析（2021年）

4. 2020 年至 2032 年全球冠状动脉支架市场（依产品类型）

  • 介绍
  • 裸金属支架
  • 药物释放型支架
  • 生物可吸收支架

5. 2020-2032 年全球冠状动脉支架市场（依材料）

  • 介绍
  • 金属
  • 聚合物

6. 全球冠状动脉支架市场（依最终用户划分），2020 年至 2032 年

  • 介绍
  • 医院
  • 专科诊所
  • 门诊手术中心

7. 2020-2032 年全球冠状动脉支架市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 东南亚国协
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东地区
  • 非洲
    • 北非
    • 中部非洲
    • 南非

第八章 竞争态势

  • Medtronic
  • iVascular
  • Alvimedica
  • Alta Biomaterials
  • Japan Medical Device Technology Co., Ltd.
  • Veritas Bioventions Pvt Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Abbott
  • SLTL Group
  • Translumina Therapeutics LLP
  • DSM
  • Arterius
  • Terumo Corporation
  • SMT
  • Boston Scientific Corporation
  • Cook
  • BIoTronik
  • B. Braun SE
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • CR Bard, Inc.
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • QualiMed
  • Elixir Medical Corporation
  • ENDOCOR GmbH & CO. KG
  • Amaranth Medical, Inc.

第九章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI2031

Coronary Stents Market is estimated to be valued at USD 13,944.9 Mn in 2025 and is expected to reach USD 23,790.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.93% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 13,944.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.93% 2032 Value Projection: USD 23,790.9 Mn

Coronary stents (CS) are expandable tubular metallic devices, which are introduced into coronary arteries, when the arteries are clogged due to an underlying atherosclerosis disease. This revascularization procedure is termed as a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement.

The coronary stent was first developed in the 1980s, and has continued to evolve in terms of shape, structure, and the material used within them.

Market Dynamics

Increasing product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, in December 2021, Svelte Medical, which is a privately-held company, dedicated to redefining the approach to coronary stenting, announced the U.S. Food and Drug Administration (FDA) approval for SLENDER Sirolimus-Eluting Coronary Stent Integrated Delivery System and DIRECT Sirolimus-Eluting Coronary Stent Rapid Exchange Delivery System, which is intended for use in patients who have a narrowing in their coronary arteries.

The increasing prevalence of coronary heart diseases is expected to drive the market growth over the forecast period. For instance, in October 2022, according to an article published by Centers for Disease Control and Prevention (CDC), stated that heart disease is the leading cause of death in the U.S. and about 20.1 million adults age 20 and older in the U.S. have Coronary Artery Disease (CAD).

Key features of the study

  • This report provides in-depth analysis of the global coronary stents market, and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global coronary stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Medtronic, iVascular, Alvimedica, Alta Biomaterials, Japan Medical Device Technology Co., Ltd., Veritas Bioventions Pvt Ltd, Nano Therapeutics Pvt. Ltd, Abbott, SLTL Group, Translumina Therapeutics LLP, DSM, Arterius, Terumo Corporation, SMT, Boston Scientific Corporation, Cook, Biotronik, B. Braun SE, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd, C. R. Bard, Inc, KYOTO MEDICAL PLANNING Co., Ltd, QualiMed, Elixir Medical Corporation, ENDOCOR GmbH & CO. KG, Amaranth Medical, Inc.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global coronary stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary stents market.

Market Segmentation

  • Global Coronary Stents Market, By Product Type
    • Bare-Metal Stents
    • Drug Eluting Stents
    • Bioabsorbable Stents
  • Global Coronary Stents Market, By Material
    • Metallic
    • Stainless Steel
    • Silicon Carbide
    • Titanium Nitride Oxide
    • Cobalt Chromium
    • Platinum Chromium
    • Others
    • Polymeric
    • Non-degradable/Permanent Stents
    • Degradable/Temporary Stents
  • Global Coronary Stents Market, By End User
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Coronary Stents Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic
    • iVascular
    • Alvimedica
    • Alta Biomaterials
    • Japan Medical Device Technology Co., Ltd.
    • Veritas Bioventions Pvt Ltd.
    • Nano Therapeutics Pvt. Ltd.
    • Abbott
    • SLTL Group
    • Translumina Therapeutics LLP
    • DSM
    • Arterius
    • Terumo Corporation
    • SMT
    • Boston Scientific Corporation
    • Cook
    • KYOTO MEDICAL PLANNING Co., Ltd.
    • QualiMed
    • Elixir Medical Corporation
    • ENDOCOR GmbH & CO. KG
    • Amaranth Medical, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Material
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Material Landscape
  • PORTER's Analysis
  • Pricing Analysis (2021)

4. Global Coronary Stents Market, By Product Type, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Bare-Metal Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Drug Eluting Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Bioabsorbable Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Coronary Stents Market, By Material, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Metallic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
      • Stainless Steel
      • Silicon Carbide
      • Titanium Nitride Oxide
      • Cobalt Chromium
      • Platinum Chromium
      • Others
  • Polymeric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
      • Non-degradable/Permanent Stents
      • Degradable/Temporary Stents

6. Global Coronary Stents Market, By End User, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Coronary Stents Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • iVascular
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alvimedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alta Biomaterials
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Japan Medical Device Technology Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Veritas Bioventions Pvt Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nano Therapeutics Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SLTL Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Translumina Therapeutics LLP
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arterius
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SMT
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B. Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Meril Life Sciences Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • C. R. Bard, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • KYOTO MEDICAL PLANNING Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • QualiMed
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elixir Medical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ENDOCOR GmbH & CO. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amaranth Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us